Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.37 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.36 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.32 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | CCR2 | P41597 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.32 |
| ▸ | TNKS | O95271 | 3/20 | 0.31 |
| ▸ | TNKS2 | Q9H2K2 | 3/20 | 0.31 |
| ▸ | CCR5 | P51681 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 2/20 | 0.31 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.31 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23778317 | 0.88 | MAPK14 (0.40) | MAPK14CHRM1KCNH2CCR2CCR5 | |
| SCHEMBL23798604 | 0.84 | OPRM1 (0.47) | MAPK14OPRM1OPRL1OPRK1HTR7 | |
| SCHEMBL23798696 | 0.83 | HRH4 (0.36) | HRH4MAPK14OPRM1OPRL1CHRM1 | |
| SCHEMBL20073891 | 0.83 | CHRM1 (0.45) | MAPK14CHRM1KCNH2CCR2 | |
| SCHEMBL29709319 | 0.83 | CHRM1 (0.45) | MAPK14CHRM1KCNH2CCR2 | |
| SCHEMBL23798012 | 0.80 | MAPK14 (0.45) | MAPK14AKR1B1 | |
| SCHEMBL23798606 | 0.76 | OPRM1 (0.40) | MAPK14AKR1B1OPRM1OPRL1OPRK1 | |
| SCHEMBL23778366 | 0.73 | HRH3 (0.40) | MAPK14HTR7 | |
| SCHEMBL24455096 | 0.73 | AKR1B1 (0.44) | AKR1B1HTR7TNKSTNKS2BRD4 | |
| SCHEMBL29621945 | 0.73 | AKR1B1 (0.44) | AKR1B1HTR7TNKSTNKS2BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3526207-B1 | HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. | HEPTARES THERAPEUTICS LTD (GB) | 2021-09-08 | — | — | EP | disclosed |